[ { "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026", "title": "Kvartalsrapport Q1 2026", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/aab8a43e74fee5eace7bce8c45a8620f8", "date": "2026-05-25", "period": "2026-q1", "form_type": "interim-report", "report_key": "2026:q1", "filename": "05256593.pdf", "text_chars": 33267, "sha256": "5d82cf9d28de6d24fe2cafdcf299b47e6f69cf52c5ded7e4ce7ab0083547a295", "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026", "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026", "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt", "parts": [ { "number": 1, "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html", "chars": 33267 } ] }, { "doc_id": "nasdaq-nordic-arsredovisning-2025", "title": "Årsredovisning 2025", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/a81b93c940a2b2561fb907e5d4868092e", "date": "2026-03-20", "period": "2025-annual", "form_type": "annual-report", "report_key": "2025:annual", "filename": "03207922.pdf", "text_chars": 284791, "sha256": "98f52adea34923f38cbece510aa866da6c82126f0c580e5291cbb9abdb60f0f5", "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2025", "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2025", "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt", "parts": [ { "number": 1, "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2025/part-001.html", "chars": 179732 }, { "number": 2, "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2025/part-002.html", "chars": 105057 } ] }, { "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025", "title": "Kvartalsrapport Q4 2025", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/a1bb32b8b6f7e30d498619f54e258bf24", "date": "2026-02-06", "period": "2025-q4", "form_type": "year-end-report", "report_key": "2025:q4", "filename": "02045726.pdf", "text_chars": 43151, "sha256": "c388d1c855910f4f5c9ba52e62b0685e49760c8f452685d125a74a427e4870b5", "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025", "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025", "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt", "parts": [ { "number": 1, "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html", "chars": 43151 } ] }, { "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2025", "title": "Kvartalsrapport Q3 2025", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/a60352723909d02bdb354d97cd07a8fe0", "date": "2025-10-24", "period": "2025-q3", "form_type": "interim-report", "report_key": "2025:q3", "filename": "10238921.pdf", "text_chars": 46826, "sha256": "9b9ee7842ea7c3f79acd844498db660d1369325111fd9f9fc529dacb619a69bc", "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025", "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025", "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt", "parts": [ { "number": 1, "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025/part-001.html", "chars": 46826 } ] }, { "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025", "title": "Kvartalsrapport Q2 2025", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/a97b92923ca6221d0b7b355374cdf8c11", "date": "2025-07-11", "period": "2025-q2", "form_type": "interim-report", "report_key": "2025:q2", "filename": "07108252.pdf", "text_chars": 42301, "sha256": "fed67fa327fcc0fe2a3c219c8466c92a00c08a61a455f69b30fe40078b228b88", "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025", "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025", "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt", "parts": [ { "number": 1, "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html", "chars": 42301 } ] }, { "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2025", "title": "Kvartalsrapport Q1 2025", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/aa09ea965d322c5501bb7401ee50c54b3", "date": "2025-04-10", "period": "2025-q1", "form_type": "interim-report", "report_key": "2025:q1", "filename": "04095665.pdf", "text_chars": 39392, "sha256": "1c826e86f766fb0916829100e81db6fc31b0edf779f85409a6d3e5c00a2bafd8", "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025", "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025", "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt", "parts": [ { "number": 1, "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025/part-001.html", "chars": 39392 } ] }, { "doc_id": "nasdaq-nordic-arsredovisning-2024", "title": "Årsredovisning 2024", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/a8a25e81acbd157814da20927ed5b497e", "date": "2025-03-06", "period": "2024-annual", "form_type": "annual-report", "report_key": "2024:annual", "filename": "03067038.pdf", "text_chars": 284435, "sha256": "0d541124ef181df99beb4ec4704da40d9ab287a48f1aeb6b3a6a71caa17206f3", "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2024", "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2024", "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt", "parts": [ { "number": 1, "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2024/part-001.html", "chars": 178821 }, { "number": 2, "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2024/part-002.html", "chars": 105612 } ] }, { "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024", "title": "Kvartalsrapport Q4 2024", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/a1f3af771049d2ccfe7dbfab35a891606", "date": "2025-02-05", "period": "2024-q4", "form_type": "year-end-report", "report_key": "2024:q4", "filename": "02042157.pdf", "text_chars": 41954, "sha256": "b5a11beb27fe3efde2a47b3fdd804df75dd2ca4c18fcb40c20d135ddda461477", "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024", "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024", "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt", "parts": [ { "number": 1, "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html", "chars": 41954 } ] }, { "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2024", "title": "Kvartalsrapport Q3 2024", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/a06d68daf7ae64e385c246f482cc074ba", "date": "2024-10-25", "period": "2024-q3", "form_type": "interim-report", "report_key": "2024:q3", "filename": "10247432.pdf", "text_chars": 44738, "sha256": "14fa98a3ab928429690d7871bcf1ae6652f53ccf1e527d17b84206f2ee01c4e6", "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024", "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024", "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt", "parts": [ { "number": 1, "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024/part-001.html", "chars": 44738 } ] }, { "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024", "title": "Kvartalsrapport Q2 2024", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/a6a2d11acb4897d1de569de15eec47bc7", "date": "2024-07-12", "period": "2024-q2", "form_type": "interim-report", "report_key": "2024:q2", "filename": "07114860.pdf", "text_chars": 41780, "sha256": "83eca184a4597906e0794eab275f815da5c0193c770926d1c29368dbf1df2c9a", "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024", "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024", "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt", "parts": [ { "number": 1, "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html", "chars": 41780 } ] }, { "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2024", "title": "Kvartalsrapport Q1 2024", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/a7a36e40e82ac82dc2446c736bd9321ad", "date": "2024-04-24", "period": "2024-q1", "form_type": "interim-report", "report_key": "2024:q1", "filename": "04236511.pdf", "text_chars": 39221, "sha256": "b13ec861cf9e4818e4f9fb1e699988603eb9495627c5f2fb55f7860c1d7d8e28", "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024", "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024", "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt", "parts": [ { "number": 1, "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024/part-001.html", "chars": 39221 } ] }, { "doc_id": "nasdaq-nordic-arsredovisning-2023", "title": "Årsredovisning 2023", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/acbe979e0c81f89598f27cd4285c03d4a", "date": "2024-03-07", "period": "2023-annual", "form_type": "annual-report", "report_key": "2023:annual", "filename": "03072581.pdf", "text_chars": 288926, "sha256": "139cf444afd331abccb74ba0d1f7a563ede9bc0029ddeea094e71af4e3e709a6", "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2023", "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2023", "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt", "parts": [ { "number": 1, "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2023/part-001.html", "chars": 178677 }, { "number": 2, "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2023/part-002.html", "chars": 110247 } ] }, { "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023", "title": "Kvartalsrapport Q4 2023", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/a52f36b84a728bf9f93a768652b782465", "date": "2024-02-09", "period": "2023-q4", "form_type": "year-end-report", "report_key": "2023:q4", "filename": "02085164.pdf", "text_chars": 40883, "sha256": "963175a0cae339404ee7f5d50c015bf3c357bee6ec60876c6ca4685c52b3a9f5", "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023", "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023", "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt", "parts": [ { "number": 1, "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html", "chars": 40883 } ] }, { "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2023", "title": "Kvartalsrapport Q3 2023", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/a8ba90b376b7b000a0c7f7c1cea1bf132", "date": "2023-10-27", "period": "2023-q3", "form_type": "interim-report", "report_key": "2023:q3", "filename": "10263062.pdf", "text_chars": 43445, "sha256": "159810e20f79e6b8554fc810a4e64c7d5a6b12e079ee0cacc088142454df6ec1", "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023", "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023", "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt", "parts": [ { "number": 1, "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023/part-001.html", "chars": 43445 } ] }, { "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023", "title": "Kvartalsrapport Q2 2023", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/a1e9d925eb1bcdc5f8940c8c70a486cb7", "date": "2023-07-14", "period": "2023-q2", "form_type": "interim-report", "report_key": "2023:q2", "filename": "07133448.pdf", "text_chars": 43490, "sha256": "214d155efff34ae01856d9c3f35cef58fd458df12920d8c0a5273e6d334acf8b", "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023", "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023", "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt", "parts": [ { "number": 1, "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html", "chars": 43490 } ] }, { "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2023", "title": "Kvartalsrapport Q1 2023", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/aa27343098804155dab684a735ac775fb", "date": "2023-04-28", "period": "2023-q1", "form_type": "interim-report", "report_key": "2023:q1", "filename": "04278325.pdf", "text_chars": 38866, "sha256": "769a8e31fad3c087af20f15ca96f98cfcad5714bbae2ae3146c16b6af816131e", "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023", "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023", "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt", "parts": [ { "number": 1, "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023/part-001.html", "chars": 38866 } ] }, { "doc_id": "mfn-mfn-bolagssida-och-bolagsmetadata", "title": "MFN bolagssida och bolagsmetadata", "source": "MFN", "source_class": "mfn", "source_url": "https://mfn.se/all/a/episurf-medical", "date": null, "period": null, "form_type": "company-page", "report_key": null, "filename": "company.txt", "text_chars": 15127, "sha256": "32c2ee05bd13fa8f03734c32f344f006f5b749795a495c72b38f92cebd318d07", "url": "/company/episurf-medical-ab/documents/mfn-mfn-bolagssida-och-bolagsmetadata", "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/mfn-mfn-bolagssida-och-bolagsmetadata", "txt_url": "/company/episurf-medical-ab/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt", "parts": [ { "number": 1, "url": "/company/episurf-medical-ab/documents/mfn-mfn-bolagssida-och-bolagsmetadata/part-001.html", "chars": 15127 } ] } ]